Adefovir Dipivoxil Market Forecast 2026–2034: Opportunities, Challenges, and Industry Insights
Adefovir dipivoxil is an orally administered antiviral medicine primarily used in the treatment of hepatitis B infection. It belongs to the acyclic nucleotide analog reverse transcriptase inhibitor class and works by limiting viral replication. Increasing attention toward the diagnosis and management of chronic viral infections, improvements in pharmaceutical treatment approaches, and continued...
0 Комментарии 0 Поделились